Swedish Orphan Biovitrum Retained Earnings (Accumulated Deficit) 2019-2025 | BIOVF
Swedish Orphan Biovitrum retained earnings (accumulated deficit) for the quarter ending June 30, 2025 were $2.426B, a 36.23% increase year-over-year.
- Swedish Orphan Biovitrum retained earnings (accumulated deficit) for 2024 were $2.074B, a 21.82% increase from 2023.
- Swedish Orphan Biovitrum retained earnings (accumulated deficit) for 2023 were $1.703B, a 8.79% increase from 2022.
- Swedish Orphan Biovitrum retained earnings (accumulated deficit) for 2022 were $1.565B, a 2.03% increase from 2021.